norketamine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chang, L; Fujita, A; Fujita, Y; Hashimoto, K; Pu, Y | 1 |
| Hashimoto, K; Luo, A; Yang, C; Yang, J | 1 |
| Ago, Y; Chen, L; Hashimoto, H; Hashimoto, K; Higuchi, M; Kasai, A; Naito, M; Nakagawa, S; Nakazawa, T; Seiriki, K; Tanabe, W; Tsukada, S; Yamaguchi, T; Yokoyama, R | 1 |
| Huang, C; Jiang, R; Liu, C; Wang, Y; Wu, Z; Xu, J; Yan, E; Yang, C; Yang, L; Zhou, L; Zhu, B | 1 |
| Hashimoto, K; Shirayama, Y | 1 |
| Buvanendran, A; Das, V; Kroin, JS; Moric, M | 1 |
| Drabik, U; Gajdosz, R; Librowski, T; Nowak, G; Popik, P; Sałat, K; Siwek, A; Starowicz, G | 1 |
| Dahan, A; Niesters, M | 1 |
2 review(s) available for norketamine and Disease Models, Animal
| Article | Year |
|---|---|
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Hippocampus; Humans; Ketamine; Prefrontal Cortex; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Stress, Psychological | 2019 |
Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
Topics: Animals; Chronic Disease; Disease Models, Animal; Humans; Ketamine; Neuralgia; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate | 2012 |
7 other study(ies) available for norketamine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Anesthetics, Dissociative; Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ketamine; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Parkinson Disease; Protein-Tyrosine Kinases; Receptor, trkB; Signal Transduction; Substantia Nigra; Tyrosine 3-Monooxygenase | 2020 |
(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Female; Ketamine; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate | 2020 |
Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression.
Topics: Animals; Antidepressive Agents; Bacteria; Depression; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Ketamine; Lipopolysaccharides; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate | 2021 |
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Helplessness, Learned; Ketamine; Male; Off-Label Use; Rats; Spermidine; Time Factors | 2018 |
Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain.
Topics: Animals; Disease Models, Animal; Female; Ketamine; Mice; Mice, Inbred C57BL; Neuralgia; Treatment Outcome | 2019 |
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.
Topics: Administration, Oral; Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ketamine; Male; Mice; Motor Activity; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Swimming; Tritium | 2015 |